Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks.

COVID-19 RT-qPCR hospital-acquired infection prevalent variant of concern wastewater-based surveillance

Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
02 2023
Historique:
revised: 20 12 2022
received: 24 10 2022
accepted: 26 12 2022
pubmed: 30 12 2022
medline: 3 3 2023
entrez: 29 12 2022
Statut: ppublish

Résumé

Wastewater-based SARS-CoV-2 surveillance enables unbiased and comprehensive monitoring of defined sewersheds. We performed real-time monitoring of hospital wastewater that differentiated Delta and Omicron variants within total SARS-CoV-2-RNA, enabling correlation to COVID-19 cases from three tertiary-care facilities with >2100 inpatient beds in Calgary, Canada. RNA was extracted from hospital wastewater between August/2021 and January/2022, and SARS-CoV-2 quantified using RT-qPCR. Assays targeting R203M and R203K/G204R established the proportional abundance of Delta and Omicron, respectively. Total and variant-specific SARS-CoV-2 in wastewater was compared to data for variant specific COVID-19 hospitalizations, hospital-acquired infections, and outbreaks. Ninety-six percent (188/196) of wastewater samples were SARS-CoV-2 positive. Total SARS-CoV-2 RNA levels in wastewater increased in tandem with total prevalent cases (Delta plus Omicron). Variant-specific assessments showed this increase to be mainly driven by Omicron. Hospital-acquired cases of COVID-19 were associated with large spikes in wastewater SARS-CoV-2 and levels were significantly increased during outbreaks relative to nonoutbreak periods for total SARS-CoV2, Delta and Omicron. SARS-CoV-2 in hospital wastewater was significantly higher during the Omicron-wave irrespective of outbreaks. Wastewater-based monitoring of SARS-CoV-2 and its variants represents a novel tool for passive COVID-19 infection surveillance, case identification, containment, and potentially to mitigate viral spread in hospitals.

Identifiants

pubmed: 36579780
doi: 10.1002/jmv.28442
pmc: PMC9880705
doi:

Substances chimiques

RNA, Viral 0
Wastewater 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28442

Subventions

Organisme : CIHR
Pays : Canada
Organisme : CIHR
ID : 448242
Pays : Canada

Informations de copyright

© 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Hadj Hassine I. Covid-19 vaccines and variants of concern: a review. Rev Med Virol. 2021;32:e2313.
Abdool Karim SS, de Oliveira T. New SARS-CoV-2 variants-clinical, public health, and vaccine implications. N Engl J Med. 2021;384(19):1866-1868.
Araf Y, Akter F, Tang Y, et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022;94(5):1825-1832.
Tao K, Tzou PL, Nouhin J, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22(12):757-773.
Amirian ES. Potential fecal transmission of SARS-CoV-2: current evidence and implications for public health. Int J Infect Dis. 2020;95:363-370.
Tang A, Tong Z, Wang H, et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerging Infect Dis. 2020;26(6):1337-1339.
Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434-435.
Jones DL, Baluja MQ, Graham DW, et al. Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Total Environ. 2020;749:141364.
He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Med. 2020;26(5):672-675.
Acosta N, Bautista MA, Waddell BJ, et al. Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban population. Water Res. 2022;220:118611.
Medema G, Heijnen L, Elsinga G, Italiaander R, Brouwer A. Presence of SARS-Coronavirus-2 RNA in sewage and correlation with reported COVID-19 prevalence in the early stage of the epidemic in The Netherlands. Environ Sci Technol Lett. 2020;7:511-516.
Ahmed W, Angel N, Edson J, et al. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total Environ. 2020;728:138764.
Zambrana W, Catoe D, Coffman MM, et al. SARS-CoV-2 RNA and N antigen quantification via wastewater at the campus level, building cluster level, and individual-building level. ACS ES&T Water. 2022;11:2025-2033.
de Araújo JC, Mota VT, Teodoro A, et al. Long-term monitoring of SARS-CoV-2 RNA in sewage samples from specific public places and STPs to track COVID-19 spread and identify potential hotspots. Sci Total Environ. 2022;838:155959.
Duvallet C, Wu F, McElroy KA, et al. Nationwide trends in COVID-19 cases and SARS-CoV-2 RNA wastewater concentrations in the United States. ACS ES&T Water. 2022;11:1899-1909.
Strike W, Amirsoleimani A, Olaleye A, et al. Development and validation of a simplified method for analysis of SARS-CoV-2 RNA in university dormitories. ACS ES&T Water. 2022;11:1984-1991.
Wang Y, Liu P, Zhang H, et al. Early warning of a COVID-19 surge on a university campus based on wastewater surveillance for SARS-CoV-2 at residence halls. Sci Total Environ. 2022;821:153291.
Acosta N, Bautista MA, Hollman J, et al. A multicenter study investigating SARS-CoV-2 in tertiary-care hospital wastewater. viral burden correlates with increasing hospitalized cases as well as hospital-associated transmissions and outbreaks. Water Res. 2021;201:117369.
Tandukar S, Sthapit N, Thakali O, et al. Detection of SARS-CoV-2 RNA in wastewater, river water, and hospital wastewater of Nepal. Sci Total Environ. 2022;824:153816.
Ahmed W, Bivins A, Smith WJM, et al. Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater. Sci Total Environ. 2022;820:153171.
Yaniv K, Ozer E, Shagan M, et al. Direct RT-qPCR assay for SARS-CoV-2 variants of concern (Alpha, B.1.1.7 and Beta, B.1.351) detection and quantification in wastewater. Environ Res. 2021;201:111653.
Graber TE, Mercier É, Bhatnagar K, et al. Near real-time determination of B.1.1.7 in proportion to total SARS-CoV-2 viral load in wastewater using an allele-specific primer extension PCR strategy. Water Res. 2021;205:117681.
Xu X, Deng Y, Ding J, et al. Real-time allelic assays of SARS-CoV-2 variants to enhance sewage surveillance. Water Res. 2022;220:118686.
Peterson SW, Lidder R, Daigle J, et al. RT-qPCR detection of SARS-CoV-2 mutations S 69-70 del, S N501Y and N D3L associated with variants of concern in Canadian wastewater samples. Sci Total Environ. 2022;810:151283.
Yu AT, Hughes B, Wolfe MK, et al. Estimating relative abundance of 2 SARS-CoV-2 variants through wastewater surveillance at 2 large metropolitan sites, United States. Emerging Infect Dis. 2022;28(5):940-947.
Lee WL, Gu X, Armas F, et al. Quantitative detection of SARS-CoV-2 Omicron BA.1 and BA.2 variants in wastewater through allele-specific RT-qPCR. medRxiv. 2022. doi:10.1101/2021.12.21.21268077
Hubert CRJ, Acosta N, Waddell BJM, et al. Tracking emergence and spread of SARS-CoV-2 Omicron variant in large and small communities by wastewater monitoring in Alberta, Canada. Emerging Infect Dis. 2022;28(9):1770-1776.
Fuzzen M, Harper NBJ, Dhiyebi HA, et al. Multiplex RT-qPCR assay (N200) to detect and estimate prevalence of multiple SARS-CoV-2 variants of concern in wastewater. medRxiv. 2022. doi:10.1101/2022.04.12.22273761
Alberta HS. COVID-19 Provincial Surveillance (COVID-19) Protocol. 2022;accessed 1 June 2022.
Wolfe MK. Invited perspective: the promise of wastewater monitoring for infectious disease surveillance. Environ Health Perspect. 2022;130(5):051302.
Pang X, Gao T, Ellehoj E, et al. Wastewater-based surveillance is an effective tool for trending COVID-19 prevalence in communities: a study of 10 major communities for 17 months in Alberta. ACS ES&T Water. 2022;11:2243-2254.
D'Aoust PM, Graber TE, Mercier E, et al. Catching a resurgence: increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations. Sci Total Environ. 2021;770:145319.
Galani A, Aalizadeh R, Kostakis M, et al. SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions. Sci Total Environ. 2022;804:150151.
Ponsford MJ, Ward TJC, Stoneham SM, et al. A systematic review and meta-analysis of inpatient mortality associated with nosocomial and community COVID-19 exposes the vulnerability of immunosuppressed adults. Front Immunol. 2021;12:744696.
Wong H, Eso K, Ip A, et al. Use of ward closure to control outbreaks among hospitalized patients in acute care settings: a systematic review. Syst Rev. 2015;4(1):152.
Wee LE, Ko KKK, Conceicao EP, et al. Linking sporadic hospital clusters during a community surge of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) B.1.617.2 delta variant: the utility of whole-genome sequencing. Infection Control & Hospital Epidemiology. 2022:1-5.
Yuan S, Ye Z-W, Liang R, et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science, 377(6604):428-433.
Thornton CS, Huntley K, Berenger BM, et al. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values. Antimicrob Resist Infect Control. 2022;11(1):28.
Brailita DM, Cushman-Vokoun AM, Wood MG, et al. Prolonged SARS-CoV-2 viral shedding in lower respiratory specimens of critically ill patients does not correlate with nasopharyngeal swab results. Infect Control Hosp Epidemiol. 2022:1-6.
Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis. 2022;22:e311-e326.
Yaniv K, Ozer E, Lewis Y, Kushmaro A. RT-qPCR assays for SARS-CoV-2 variants of concern in wastewater reveals compromised vaccination-induced immunity. Water Res. 2021;207:117808.
Feng S, Roguet A, McClary-Gutierrez JS, et al. Evaluation of sampling, analysis, and normalization methods for SARS-CoV-2 concentrations in wastewater to assess COVID-19 burdens in Wisconsin Communities. ACS ES&T Water. 2021;1(8):1955-1965.
Maal-Bared R, Qiu Y, Li Q, et al. Does normalization of SARS-CoV-2 concentrations by pepper mild mottle virus improve correlations and lead time between wastewater surveillance and clinical data in Alberta (Canada) comparing twelve SARS-CoV-2 normalization approaches. Sci Total Environ. 2022;856:158964.
Condon M, Mannion E, Molloy D, O'Caoimh R. Urinary and faecal incontinence: point prevalence and predictors in a university hospital. Int J Environ Res Public Health. 2019;16(2):194.
Toba K, Ouchi Y, Orimo H, et al. Urinary incontinence in elderly inpatients in Japan: a comparison between general and geriatric hospitals. Aging Clin Exp Res. 1996;8(1):47-54.

Auteurs

Nicole Acosta (N)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Maria A Bautista (MA)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Barbara J Waddell (BJ)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Kristine Du (K)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Janine McCalder (J)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Biological Sciences, University of Calgary, Calgary, Canada.

Puja Pradhan (P)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Biological Sciences, University of Calgary, Calgary, Canada.

Navid Sedaghat (N)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Biological Sciences, University of Calgary, Calgary, Canada.

Chloe Papparis (C)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Biological Sciences, University of Calgary, Calgary, Canada.

Alexander Buchner Beaudet (AB)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Jianwei Chen (J)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Jennifer Van Doorn (J)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Kevin Xiang (K)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Leslie Chan (L)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Laura Vivas (L)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Kashtin Low (K)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Xuewen Lu (X)

Department of Mathematics and Statistics, University of Calgary, Calgary, Canada.

Jangwoo Lee (J)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.

Paul Westlund (P)

C.E.C. Analytics Ltd., Calgary, Canada.

Thierry Chekouo (T)

Department of Mathematics and Statistics, University of Calgary, Calgary, Canada.
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.

Xiaotian Dai (X)

Department of Mathematics and Statistics, University of Calgary, Calgary, Canada.

Jason Cabaj (J)

Department of Community Health Sciences, University of Calgary, Calgary, Canada.
Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Provincial Population & Public Health, Alberta Health Services, Calgary, Canada.
O'Brien Institute for Public Health, University of Calgary, Calgary, Canada.

Srijak Bhatnagar (S)

Faculty of Science and Technology, Athabasca University, Athabasca, Alberta, Canada.

Norma Ruecker (N)

Water Services, City of Calgary, Calgary, Canada.

Gopal Achari (G)

Department of Civil Engineering, University of Calgary, Calgary, Canada.

Rhonda G Clark (RG)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Craig Pearce (C)

Infection Prevention and Control, Alberta Health Services, Calgary, Canada.

Joe J Harrison (JJ)

Department of Biological Sciences, University of Calgary, Calgary, Canada.
Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, Canada.

Jon Meddings (J)

Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.

Jenine Leal (J)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, Canada.
O'Brien Institute for Public Health, University of Calgary, Calgary, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.

Jennifer Ellison (J)

Infection Prevention and Control, Alberta Health Services, Calgary, Canada.

Bayan Missaghi (B)

Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.

Jamil N Kanji (JN)

Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Alberta Precision Laboratories, Public Health Laboratory, Alberta Health Services, Edmonton, Alberta, Canada.
Department of Pathology and Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.

Oscar Larios (O)

Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.
Alberta Precision Laboratories, Public Health Laboratory, Alberta Health Services, Edmonton, Alberta, Canada.

Elissa Rennert-May (E)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Community Health Sciences, University of Calgary, Calgary, Canada.
Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
O'Brien Institute for Public Health, University of Calgary, Calgary, Canada.
Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, Canada.

Joseph Kim (J)

Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.

Steve E Hrudey (SE)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Department of Analytical and Environmental Toxicology, University of Alberta, Edmonton, Alberta, Canada.

Bonita E Lee (BE)

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Women & Children's Health Research Institute, Edmonton, Alberta, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.

Xiaoli Pang (X)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Alberta Precision Laboratories, Public Health Laboratory, Alberta Health Services, Edmonton, Alberta, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.

Kevin Frankowski (K)

Advancing Canadian Water Assets, University of Calgary, Calgary, Canada.

John Conly (J)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
O'Brien Institute for Public Health, University of Calgary, Calgary, Canada.
Infection Prevention and Control, Alberta Health Services, Calgary, Canada.
Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, Canada.
Department of Pathology and Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.

Casey R J Hubert (CRJ)

Department of Biological Sciences, University of Calgary, Calgary, Canada.

Michael D Parkins (MD)

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Department of Medicine, University of Calgary and Alberta Health Services, Calgary, Canada.
Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH